Literature DB >> 29149929

Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Ethan Craig1, Laura C Cappelli2.   

Abstract

Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antirheumatic medications (DMARDs); Gastrointestinal disease; Hepatic disease; Rheumatoid arthritis

Mesh:

Substances:

Year:  2018        PMID: 29149929      PMCID: PMC5726432          DOI: 10.1016/j.rdc.2017.09.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  191 in total

1.  Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Authors:  Antonio Fernández-Nebro; Eva Tomero; Vera Ortiz-Santamaría; María Carmen Castro; Alejandro Olivé; Manuel de Haro; Rosa García Portales; Rosa García-Vicuña; María Victoria González-Mari; Armando Laffón; Rosario García-Vicuña
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

2.  Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis.

Authors:  T Keersmaekers; K Claes; D R Kuypers; K de Vlam; P Verschueren; R Westhovens
Journal:  Ann Rheum Dis       Date:  2009-05       Impact factor: 19.103

3.  Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series.

Authors:  S Bernard; R Germi; J Lupo; M-H Laverrière; V Masse; P Morand; G Gavazzi
Journal:  Clin Microbiol Infect       Date:  2015-05-22       Impact factor: 8.067

4.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

Review 5.  Jejunoileal bypass arthritis.

Authors:  C B Ross; H W Scott; T Pincus
Journal:  Baillieres Clin Rheumatol       Date:  1989-08

6.  Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.

Authors:  Ippei Miyagawa; Shingo Nakayamada; Kazuyoshi Saito; Kentaro Hanami; Masao Nawata; Norifumi Sawamukai; Kazuhisa Nakano; Kunihiro Yamaoka; Yoshiya Tanaka
Journal:  Mod Rheumatol       Date:  2013-10-21       Impact factor: 3.023

7.  Hepatic hemorrhage in malignant rheumatoid arthritis.

Authors:  K Mizuno; K Ikeda; Y Saida; R Takenaka; M Shibata; T Takeuchi
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

8.  Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis.

Authors:  Xiaofei Liu; Qinghua Zou; Benhua Zeng; Yongfei Fang; Hong Wei
Journal:  Curr Microbiol       Date:  2013-03-13       Impact factor: 2.188

9.  Fecal microbiota in early rheumatoid arthritis.

Authors:  Jussi Vaahtovuo; Eveliina Munukka; Mika Korkeamäki; Reijo Luukkainen; Paavo Toivanen
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

10.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors:  R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

View more
  9 in total

Review 1.  Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?

Authors:  Salvatore Di Bartolomeo; Francesco Carubbi; Paola Cipriani
Journal:  BMC Rheumatol       Date:  2020-09-21

2.  Clinical outcomes and resource utilization analysis in patients with rheumatoid arthritis undergoing endoscopic retrograde cholangiopancreatography.

Authors:  Ahmed Ahmed; Aaron Kahlam; Suraj Pai; Sushil Ahlawat
Journal:  JGH Open       Date:  2021-02-19

3.  Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology.

Authors:  Francesco Carubbi; Giovanna Picchi; Salvatore Di Bartolomeo; Alessandra Ricciardi; Paola Cipriani; Laura Marola; Alessandro Grimaldi; Roberto Giacomelli
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 4.  Endothelial Dysfunction and Extra-Articular Neurological Manifestations in Rheumatoid Arthritis.

Authors:  Jessica Maiuolo; Carolina Muscoli; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Sara Paone; Sara Ilari; Rocco Mollace; Ernesto Palma; Vincenzo Mollace
Journal:  Biomolecules       Date:  2021-01-10

5.  Anti-Inflammatory and Anti-Arthritic Potential of Standardized Extract of Clerodendrum serratum (L.) Moon.

Authors:  Raj Kumar Tiwari; Silpi Chanda; Udayabanu M; Manisha Singh; Shriya Agarwal
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

6.  Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic.

Authors:  Eltaib Saad; Abdalaziz Awadelkarim; Mohamed Agab; Akram Babkir
Journal:  J Med Cases       Date:  2022-03-05

Review 7.  Natural medicines of targeted rheumatoid arthritis and its action mechanism.

Authors:  Xueling Liu; Zhiguo Wang; Hua Qian; Wenhua Tao; Ying Zhang; Chunyan Hu; Weiwei Mao; Qi Guo
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 8.  Imaging of intestinal vasculitis focusing on MR and CT enterography: a two-way street between radiologic findings and clinical data.

Authors:  Mehrnam Amouei; Sara Momtazmanesh; Hoda Kavosi; Amir H Davarpanah; Ali Shirkhoda; Amir Reza Radmard
Journal:  Insights Imaging       Date:  2022-09-04

9.  [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].

Authors:  Larissa Valor-Méndez; Bernhard Manger; Georg Schett; Arnd Kleyer
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.